Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 11 04:00PM ET
2.90
Dollar change
+0.05
Percentage change
1.75
%
Index- P/E- EPS (ttm)-26.09 Insider Own1.57% Shs Outstand3.12M Perf Week1.05%
Market Cap9.05M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.07M Perf Month-13.17%
Income-18.56M PEG- EPS next Q- Inst Own0.55% Short Float0.17% Perf Quarter-29.27%
Sales4.33M P/S2.09 EPS this Y- Inst Trans- Short Ratio0.92 Perf Half Y-60.50%
Book/sh6.41 P/B0.45 EPS next Y- ROA-43.04% Short Interest0.01M Perf Year-67.63%
Cash/sh6.41 P/C0.45 EPS next 5Y- ROE-80.20% 52W Range2.62 - 11.10 Perf YTD-61.02%
Dividend Est.- P/FCF- EPS past 5Y- ROI-87.46% 52W High-73.87% Beta1.51
Dividend TTM- Quick Ratio3.05 Sales past 5Y103.89% Gross Margin37.30% 52W Low10.69% ATR (14)0.20
Dividend Ex-Date- Current Ratio3.46 EPS Y/Y TTM-35.52% Oper. Margin-486.85% RSI (14)41.51 Volatility5.04% 6.93%
Employees21 Debt/Eq0.08 Sales Y/Y TTM-36.86% Profit Margin-428.43% Recom1.00 Target Price60.00
Option/ShortNo / Yes LT Debt/Eq0.06 EPS Q/Q45.74% Payout- Rel Volume0.84 Prev Close2.85
Sales Surprise- EPS Surprise- Sales Q/Q62266.67% EarningsNov 12 BMO Avg Volume5.58K Price2.90
SMA20-3.06% SMA50-14.29% SMA200-50.11% Trades Volume4,632 Change1.75%
COSCIENS Biopharma Inc. Is a specialty biopharmaceutical company, which engages in the development and commercialization of diverse pharmaceutical and diagnostic products. The company is headquartered in Toronto, Canada.